BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15720069)

  • 1. Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
    Chen WC; Lo GH; Lai KH; Cheng JS; Hsu PI; Lin CK
    J Chin Med Assoc; 2004 Nov; 67(11):557-64. PubMed ID: 15720069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
    Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma.
    Akanuma M; Yoshida H; Okamoto M; Ogura K; Maeda S; Hata Y; Sato S; Shiina S; Kawabe T; Shiratori Y; Omata M
    Hepatogastroenterology; 2002; 49(46):1039-44. PubMed ID: 12143197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
    Hori S; Takaki A; Okada H; Fujiwara A; Takenaka R; Makidono C; Shiratori Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1704-9. PubMed ID: 16984593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study.
    Kawai T; Yashima Y; Sugimoto T; Sato T; Kanda M; Enomoto N; Sato S; Obi S
    World J Surg Oncol; 2016 Feb; 14():52. PubMed ID: 26911980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.
    Wu CK; Liang CM; Hsu CN; Hung TH; Yuan LT; Nguang SH; Wang JW; Tseng KL; Ku MK; Yang SC; Tai WC; Shih CW; Hsu PI; Wu DC; Chuah SK
    PLoS One; 2017; 12(1):e0169884. PubMed ID: 28118373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices.
    Nakayama H; Masuda H; Miyake H; Takayama T; Yokoyama E
    Digestion; 2004; 70(4):233-9. PubMed ID: 15627772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Velázquez RF; Rodríguez M; Navascués CA; Linares A; Pérez R; Sotorríos NG; Martínez I; Rodrigo L
    Hepatology; 2003 Mar; 37(3):520-7. PubMed ID: 12601348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome.
    Paik CN; Kim SW; Lee IS; Park JM; Cho YK; Choi MG; Chung IS
    J Clin Gastroenterol; 2008 Sep; 42(8):916-22. PubMed ID: 18645533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma.
    Letier MH; Krige JE; Lemmer ER; Terblanche J
    Hepatogastroenterology; 2000; 47(36):1680-4. PubMed ID: 11149031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
    Kim JH; Sinn DH; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2016 Nov; 61(11):3354-3362. PubMed ID: 27435325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.
    Park DK; Um SH; Lee JW; Lee JB; Kim YS; Park CH; Jin YT; Chun HJ; Lee HS; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1042-51. PubMed ID: 15304123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis.
    Wu CY; Yeh HZ; Chen GH
    J Clin Gastroenterol; 2002 Aug; 35(2):127-32. PubMed ID: 12172356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance and prediction factors of gastric varices in patients with hepatocellular carcinoma.
    Yeh JL; Peng YC; Tung CF; Yang DY; Hu WH; Chow WK; Yeh HZ; Chen GH
    Hepatogastroenterology; 2003; 50(53):1603-8. PubMed ID: 14571795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers].
    Silva M; Mattos AA; Fontes PR; Waechter FL; Pereira-Lima L
    Arq Gastroenterol; 2008; 45(2):99-105. PubMed ID: 18622461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive Protein Can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding.
    Ichikawa T; Machida N; Kaneko H; Oi I; A Fujino M
    Intern Med; 2019 Feb; 58(4):487-495. PubMed ID: 30333404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher free serum cortisol is associated with worse survival in acute variceal bleeding because of cirrhosis: a prospective study.
    Triantos CK; Kalafateli M; Samonakis D; Zisimopoulos K; Papiamonis N; Sapountzis A; Michalaki M; Theocharis G; Thomopoulos K; Labropoulou-Karatza C; Kyriazopoulou V; Jelastopulu E; Kouroumalis EA; Nikolopoulou V; Burroughs AK
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1125-32. PubMed ID: 25089543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.